Smaller Indian pharma companies bore the strongest impact from COVID-19 pandemic – MedicinMan Indian Pharma Digital Adoption Survey Smaller Indian pharma companies with less than a 100 MSRs and less than Rs.100 Cr. turnover were the most highly impacted from the COVID-19 pandemic in the last 12 months. That can be explained by the fact…
Free Membership Required
You must be a Free member to access this content.
Already a member? Log in here
